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Adjunctive Thrombectomy in
Acute Myocardial Infarction:
For Some but Not for All
We read with interest the report by Silva-Orrego et al. (1)
regarding the effects of thrombus aspiration on myocardial reper-
fusion in the setting of primary angioplasty. The study reported a
significant enhancement in myocardial reperfusion by a strategy of
manual thrombus aspiration before stenting on top of abciximab
administration. However, in our opinion some concerns exist
about the results of this study. First, the investigators randomized
patients with acute myocardial infarction (MI) to a conventional
stent-assisted primary angioplasty versus a strategy applying man-
ual aspiration device before stent, regardless of angiographic
appearance of thrombus. Early studies evaluating the feasibility of
thrombectomy in the setting of thrombus-containing lesion and
acute MI clearly reported on the efficacy of thrombectomy devices
in reducing thrombus burden at target lesion, consequently limit-
ing distal embolization and no-reflow phenomenon (2,3).
Unfortunately, Silva-Orrego et al. (1) did not provide data
concerning thrombus burden at baseline angiography, nor on
thrombus removal after device use. Thus, the reported reduction in
distal embolization rate may not be univocally ascribed to the
device effect, as other factors may affect this result, such as
differences in thrombus burden of culprit lesions.
Second, the researchers found a rate of postprocedural myocar-
dial blush grade (MBG) 2/3 in both arms, which is surprisingly
higher than expected, based on Thrombolysis In Myocardial
Infarction (TIMI) flow achieved after the intervention, and on
time-to-treatment reported in this cohort. In the largest study
validating the angiographic reperfusion, MBG was strongly af-
fected by epicardial flow, being that patients showing TIMI flow
grade 3 very rarely reached an adequate blush (4). Indeed, it has
been shown that the effectiveness of myocardial reperfusion after
primary angioplasty, as assessed by ST-segment resolution and
MBG is clearly time-dependent (5).
In conclusion, to avoid conflicting results, we believe that future
studies evaluating thrombectomy as adjunctive strategy in the
setting of primary angioplasty should enroll only patients with
angiographically documented thrombus at the lesion site, and that
reperfusion findings should be carefully evaluated according to
time-to-treatment.
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Reply
We appreciated the comments by Dr. Napodano and colleagues
and would like to address their concern. The DEAR-MI (De-
thrombosis to Enhance Acute Reperfusion in Myocardial Infarc-
tion) study (1) included consecutive randomization of acute myo-
cardial infarction (AMI) patients fulfilling the inclusion criteria
regardless of angiographic evidence of thrombus based on the
assumption that thrombus is always present in AMI. Compared
with angioscopy, the presence of intracoronary thrombus is signif-
icantly underestimated by angiography (2). In our randomized
population, 73% of controls and 81% of patients undergoing
aspiration showed an occluded vessel with Thrombolysis In Myo-
cardial Infarction (TIMI) flow grade 0/1 at the initial angiogram,
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